MLchartDataset catalogue

carcinoembryonic antigen peptide 1-6D

Term · Oncology and biomedicine · MLC-T-ONC-012303

A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.

Table 1. Record
IdentifierMLC-T-ONC-012303
FieldOncology and biomedicine
AbbreviationCEA PEP 1-6D
SynonymsCEA:571-579 (576D); modified CEA peptide; mCEA peptide
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012303",
  "term": "carcinoembryonic antigen peptide 1-6D",
  "field": "Oncology and biomedicine",
  "definition": "A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.",
  "abbreviation": "CEA PEP 1-6D",
  "synonyms": [
    "CEA:571-579 (576D)",
    "modified CEA peptide",
    "mCEA peptide"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/carcinoembryonic-antigen-peptide-1-6d/"
}

Record 4,219 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.